IP Library Granted Patent US 10,550,395
Granted Patent B2
US 10,550,395 · App. 15/947,315 · Granted Feb 4, 2020

Materials and methods for rapid and sensitive detection of small-molecule targets

Inventors: Yi Xiao (Miami, FL); Haixiang Yu (Miami, FL)
Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES
C12N15/115G01N33/92G01N33/946C12N2310/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,550,395
App. No.
15/947,315
Granted
Feb 4, 2020
Kind
B2
Abstract

The subject invention provides methods, assays and products for detecting small-molecules in a sample, in particular, in both clinical and field settings. The method for detecting a small-molecule target in a sample comprises providing a sample, contacting the sample with an aptamer-based sensor selective for the small-molecule target, and sensitively and rapidly detecting the small-molecule target in the sample. Specifically, the method utilizes EATR-amplified small-molecule sensors based on cooperative binding split aptamers (CBSAs).

Claims (8)

1. A cooperative binding split aptamer (CBSA)-based enzyme-assisted target recycling (EATR)-amplified sensor comprising a CBSA, wherein the CBSA comprises SEQ ID NO:8 and SEQ ID NO:2.

2. The CBSA-based EATR-amplified sensor according to claim 1 , the CBSA being modified by addition of a reporter label.

3. The CBSA-based EATR-amplified sensor according to claim 2 , the reporter label being a fluorescent dye, a gold nanoparticle (AuNP), or a fluorescent dye and quencher pair.

4. A cooperative binding split aptamer (CBSA)-based enzyme-assisted target recycling (EATR)-amplified sensor comprising a CBSA, wherein the CBSA comprises SEQ ID NO:3 and SEQ ID NO:2.

5. A method for detecting dehydroisoandrosterone-3-sulfate (DIS) in a sample comprising contacting the sample with the CBSA-based EATR-amplified sensor of claim 4 .

6. The method according to claim 5 , the CBSA being recognized and cleaved by Exo III at a C3 spacer abasic site.

7. The method according to claim 5 , the sample being selected from blood, plasma, urine, tears, and saliva.

8. The method according to claim 5 , the method further comprising detecting a signal, the signal being a change in fluorescence intensity.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 17, 2020
From: FLORIDA INTERNATIONAL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052183/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2018
From: XIAO, YI; YU, HAIXIANG
To: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES
Reel/Frame 045764/0675 →
Continuity (1)
Related Publication 20190309296A1 · Oct 10, 2019